Condition
Narcolepsy Type 1 (NT1) clinical trials and research
Research outlook What's coming for Narcolepsy: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Narcolepsy Type 1 (NT1) clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). 1 was first registered in the last 30 days. By phase: Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 2Countries
All recruiting trials (2)
-
Ofatumumab for drug-refractory Narcolepsy Type 1
Aims to see if a single dose of ofatumumab helps people with Narcolepsy Type 1 who have not responded to previous treatments.
-
VX-433 first‑in‑human safety and PK study in healthy volunteers
This study tests the safety, how VX-433 behaves in the body, and possible drug interactions in healthy adults, to see if it’s suitable for people with narcolepsy type 1 in the future.
Related topics
Quick answers
How many Narcolepsy Type 1 (NT1) clinical trials are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.